EUVIMEDEUVIMED entdecken
Crossref

A Review on CRISPR: Revolutionizing Genetic Editing for Inherited Diseases

Bill Tawil

Scholastic Medical Sciences · 23.01.2025 · 01

DOI: 10.67735/scms.2025.02.0082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scholastic Medical Sciences, online erschienen am 23.01.2025. Verfasst von Bill Tawil.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR technology has opened transformative avenues for treating genetic disorders by offering precision at the molecular level, with applications in complex diseases like sickle cell anemia (SCA) and Leber congenital amaurosis (LCA). CRISPR’s ability to correct disease-causing mutations at their genetic roots allows for approaches that move beyond traditional symptom-focused therapies. In SCA, CRISPR-Cas9 enables direct editing of the HBB gene within hematopoietic stem cells, with the potential to offer a single, curative treatment that significantly reduces disease complications. This breakthrough holds promise for reducing the frequency of painful Vaso-occlusive crises and mitigating other systemic effects, presenting a pivotal advancement in the management of SCA. Similarly, CRISPR applications in LCA, particularly targeting mutations in genes like RPE65 and CEP290, represent a novel approach to restoring vision in patients with congenital blindness. Clinical trials in CRISPR-based gene therapies have shown potential for partial vision restoration, a remarkable feat for patients who previously had no therapeutic options. However, as CRISPR technology advances, challenges such as precise delivery, managing immune responses, and minimizing off-target effects remain critical. Efforts to improve adeno-associated viral (AAV) vectors for safer and more efficient delivery, along with neuroprotective and combination therapies, are paving the way for more durable outcomes. Overall, CRISPR’s adaptability and targeted precision underscore its potential to reshape the landscape of genetic medicine, offering renewed hope for individuals with inherited disorders.

Zitieren

APA

Tawil, B. (2025). A Review on CRISPR: Revolutionizing Genetic Editing for Inherited Diseases. Scholastic Medical Sciences, 01. https://doi.org/10.67735/scms.2025.02.0082

Vancouver

Tawil B. A Review on CRISPR: Revolutionizing Genetic Editing for Inherited Diseases. Scholastic Medical Sciences. 2025:01. doi:10.67735/scms.2025.02.0082

BibTeX
@article{Tawil2025,
  author = {Tawil, Bill},
  title = {A Review on CRISPR: Revolutionizing Genetic Editing for Inherited Diseases},
  journal = {Scholastic Medical Sciences},
  year = {2025},
  pages = {01},
  doi = {10.67735/scms.2025.02.0082}
}
Kostenlos starten →